These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7097914)
21. A prospective cohort study of oral contraceptives and cancer of the endometrium. Trapido EJ Int J Epidemiol; 1983 Sep; 12(3):297-300. PubMed ID: 6629618 [TBL] [Abstract][Full Text] [Related]
22. [Morphofunctional features of the cervix uteri in women using hormonal contraception]. Prilepskaia VN; Kondrikov NI; Nazarova NM Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353 [TBL] [Abstract][Full Text] [Related]
24. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174 [TBL] [Abstract][Full Text] [Related]
25. The safety of oral contraceptives: epidemiologic insights from the first 30 years. Grimes DA Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284 [TBL] [Abstract][Full Text] [Related]
26. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill. Hodsman GP; Robertson JI; Semple PF; Mackay A Eur Heart J; 1982 Jun; 3(3):255-9. PubMed ID: 6809465 [No Abstract] [Full Text] [Related]
27. More critics raise voices against estrogen therapy. JAMA; 1976 Feb; 235(8):787-8. PubMed ID: 12229501 [TBL] [Abstract][Full Text] [Related]
28. Effect of oral contraceptives on plasma testosterone concentration. Browning MC; Anderson J Br Med J; 1977 Jan; 1(6053):107. PubMed ID: 832008 [TBL] [Abstract][Full Text] [Related]
29. Risk factors in endometrial carcinoma with special reference to the use of estrogens. Salmi T Acta Obstet Gynecol Scand Suppl; 1979; 86():1-119. PubMed ID: 377899 [No Abstract] [Full Text] [Related]
30. Effect of switching with oral contraceptives. Wassef SA; Sami G; Hamid EA Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511 [TBL] [Abstract][Full Text] [Related]
31. Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA; 1983 Mar; 249(12):1600-4. PubMed ID: 6338265 [TBL] [Abstract][Full Text] [Related]
32. Endometrial cancer, epidemiology, and medical practice. Ryan KJ JAMA; 1982 Jan 22-29; 247(4):496. PubMed ID: 7054554 [No Abstract] [Full Text] [Related]
33. The combined oral contraceptive. Risks and adverse effects in perspective. Bagshaw S Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340 [TBL] [Abstract][Full Text] [Related]
34. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438 [TBL] [Abstract][Full Text] [Related]
35. Current perspectives on combination oral contraceptives. Smith MA; Youngkin EQ Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284 [TBL] [Abstract][Full Text] [Related]
36. Endometrial cancer trends in England and Wales: a possible protective effect of oral contraception. Villard L; Murphy M Int J Epidemiol; 1990 Jun; 19(2):255-8. PubMed ID: 2376432 [TBL] [Abstract][Full Text] [Related]
37. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat. Algeri S; Ponzio F; Dolfini E; Jori A Neuroendocrinology; 1976; 22(4):343-51. PubMed ID: 1030500 [TBL] [Abstract][Full Text] [Related]